Search results

Search for "PLGA" in Full Text gives 60 result(s) in Beilstein Journal of Nanotechnology.

Biomimetic chitosan with biocomposite nanomaterials for bone tissue repair and regeneration

  • Se-Kwon Kim,
  • Sesha Subramanian Murugan,
  • Pandurang Appana Dalavi,
  • Sebanti Gupta,
  • Sukumaran Anil,
  • Gi Hun Seong and
  • Jayachandran Venkatesan

Beilstein J. Nanotechnol. 2022, 13, 1051–1067, doi:10.3762/bjnano.13.92

Graphical Abstract
  • . Different kinds of polymeric materials have been utilized including chitosan, alginate, fucoidan, carrageenan, and ulvan from natural polymeric materials. Polycaprolactone (PCL), poly ᴅ,ʟ-lactic-co-glycolic acid (PLGA), and polylactic acid (PLA) have been extensively studied with hydroxyapatite to develop
  • fabrication of scaffolds for cartilage tissue engineering applications. The 2 cm × 2 cm PLGA electrospun nanofibers were prepared by electrospinning which incorporated those with hydroxybutyl chitosan hydrogels. The polycaprolactone scaffold was 3D printed and reinforced with hydrogel scaffolds to mimic the
PDF
Review
Published 29 Sep 2022

Gelatin nanoparticles with tunable mechanical properties: effect of crosslinking time and loading

  • Agnes-Valencia Weiss,
  • Daniel Schorr,
  • Julia K. Metz,
  • Metin Yildirim,
  • Saeed Ahmad Khan and
  • Marc Schneider

Beilstein J. Nanotechnol. 2022, 13, 778–787, doi:10.3762/bjnano.13.68

Graphical Abstract
  • . demonstrated the impact of the measurement setup for polymeric nanoparticles [4]. Young’s moduli obtained by measurements conducted on bulk materials and nanoparticles composed of PLA and PLGA vary significantly from each other. Furthermore, they showed the impact of measurements in water and at physiological
PDF
Album
Full Research Paper
Published 16 Aug 2022

Fabrication and testing of polymer microneedles for transdermal drug delivery

  • Vahid Ebrahiminejad,
  • Zahra Faraji Rad,
  • Philip D. Prewett and
  • Graham J. Davies

Beilstein J. Nanotechnol. 2022, 13, 629–640, doi:10.3762/bjnano.13.55

Graphical Abstract
  • (PLGA) MNs with a similar base diameter (200 μm) and lengths (700–1500 μm) [22]. Simulation and experimental investigation on MN insertion force To investigate the insertion force and failure modes of MN arrays into the skin, the insertion of a single MN was simulated using FEA software. Figure 6a
PDF
Album
Full Research Paper
Published 08 Jul 2022

Stimuli-responsive polypeptide nanogels for trypsin inhibition

  • Petr Šálek,
  • Jana Dvořáková,
  • Sviatoslav Hladysh,
  • Diana Oleshchuk,
  • Ewa Pavlova,
  • Jan Kučka and
  • Vladimír Proks

Beilstein J. Nanotechnol. 2022, 13, 538–548, doi:10.3762/bjnano.13.45

Graphical Abstract
  • ) (PLGA) nanoparticles loaded with AAT were successfully manufactured and AAT release profiles from the nanoparticles were investigated [21][22]. In our previous studies, we investigated and described in detail the process of nanogelation from Nα-ʟ-lysine-grafted α,β-poly[(2-propyne)-ᴅ,ʟ-aspartamide-ran
  • studies using PLGA particles as delivery system for AAT [21][22]. However, the PLGA particles did not exhibit any undesired entrapment of AAT as the polypeptide nanogels did. In contrast, our polypeptide nanogels are more advantageous due to the fact that they have a more favorable size, are soft, and
PDF
Album
Full Research Paper
Published 22 Jun 2022

Micro- and nanotechnology in biomedical engineering for cartilage tissue regeneration in osteoarthritis

  • Zahra Nabizadeh,
  • Mahmoud Nasrollahzadeh,
  • Hamed Daemi,
  • Mohamadreza Baghaban Eslaminejad,
  • Ali Akbar Shabani,
  • Mehdi Dadashpour,
  • Majid Mirmohammadkhani and
  • Davood Nasrabadi

Beilstein J. Nanotechnol. 2022, 13, 363–389, doi:10.3762/bjnano.13.31

Graphical Abstract
  • ) (PLGA) microspheres coated with TGF-β3 loaded heparin/poly(ʟ-lysine) NPs showed extended growth factor release for 28 days and were found to be excellent structures for cell adhesion and chondrogenic differentiation [27]. Apart from serving as cell adhesion platforms and growth factor supplements
  • , microsphere structures can be independently used as carriers for the delivery of drugs and bioactive molecules to repair cartilage defects. The sustained release of PTH (1-34) from PLGA microspheres improved papain-induced defects in a rat model of OA and retained the bioactivity of the released peptide up to
  • 19 days [28]. In another study, researchers developed PLGA-based microspheres to control the release of rapamycin in the joint [29]. The microspheres provided sustained and controlled release of rapamycin for several weeks, retained drug potency, and prevented OA-like changes in chondrocytes cultured
PDF
Album
Review
Published 11 Apr 2022

Effects of drug concentration and PLGA addition on the properties of electrospun ampicillin trihydrate-loaded PLA nanofibers

  • Tuğba Eren Böncü and
  • Nurten Ozdemir

Beilstein J. Nanotechnol. 2022, 13, 245–254, doi:10.3762/bjnano.13.19

Graphical Abstract
  • produce ampicillin trihydrate-loaded poly(lactic acid) (PLA) and PLA/poly(lactic-co-glycolic acid) (PLA/PLGA) polymeric nanofibers via electrospinning using 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) as the solvent for local application in tissue engineering. The effects of ampicillin trihydrate
  • concentration (4–12%) and addition of PLGA (20–80%) on the spinnability of the solutions, morphology, average nanofiber diameter, encapsulation efficiency, drug release, and mechanical properties of PLA and PLA/PLGA nanofibers were examined. All nanofibers were bead-free and uniform. They had favorable
  • and controlled drug release for ten days was obtained with nanofibers containing 8% of drug. Thus, the ideal drug concentration was determined to be 8%. Nanofibers containing PLA/PLGA had a larger diameter than those including PLA. In addition, both the strength and elongation of nanofibers decreased
PDF
Album
Full Research Paper
Published 21 Feb 2022

Engineered titania nanomaterials in advanced clinical applications

  • Padmavati Sahare,
  • Paulina Govea Alvarez,
  • Juan Manual Sanchez Yanez,
  • Gabriel Luna-Bárcenas,
  • Samik Chakraborty,
  • Sujay Paul and
  • Miriam Estevez

Beilstein J. Nanotechnol. 2022, 13, 201–218, doi:10.3762/bjnano.13.15

Graphical Abstract
  • contributes to hydroxyapatite (HA) formation and bone matrix mineralization [71]. Likewise, nanophase titania/poly(lactic-co-glycolic acid) (PLGA) composites have been designed that showed greater osteoblast adhesion compared to plain PLGA [72]. In vivo tissue engineering (TE) holds tremendous potential in
PDF
Album
Review
Published 14 Feb 2022

Use of nanosystems to improve the anticancer effects of curcumin

  • Andrea M. Araya-Sibaja,
  • Norma J. Salazar-López,
  • Krissia Wilhelm Romero,
  • José R. Vega-Baudrit,
  • J. Abraham Domínguez-Avila,
  • Carlos A. Velázquez Contreras,
  • Ramón E. Robles-Zepeda,
  • Mirtha Navarro-Hoyos and
  • Gustavo A. González-Aguilar

Beilstein J. Nanotechnol. 2021, 12, 1047–1062, doi:10.3762/bjnano.12.78

Graphical Abstract
  • -loaded polymeric (PNP with PLGA) and lipid nanoparticles (SLN with hydrogenated coco-glycerides and poloxamer 188). They reported greater stability at 135 days (>90% retention), lower average particle size (127.10 ± 11.30 nm), and higher EE% (90.49 ± 1.20%) in CUR-SL, as compared to CUR-PNP (338.20
  • inhibiting nitric oxide in cancer cells [14]. Dev et al. [142] reported that CUR-loaded BSA nanoparticles (6 µM) exposed to blue LED light inhibited the growth of glioblastoma stem cells better than F-CUR, which was attributed to an improved sustained intracellular release of CUR. Curcumin-loaded PLGA [poly
PDF
Album
Review
Published 15 Sep 2021

An overview of microneedle applications, materials, and fabrication methods

  • Zahra Faraji Rad,
  • Philip D. Prewett and
  • Graham J. Davies

Beilstein J. Nanotechnol. 2021, 12, 1034–1046, doi:10.3762/bjnano.12.77

Graphical Abstract
  • microneedles of soluble poly(lactic-co-glycolic acid) (PLGA) and PLGA–polyvinylpyrrolidone (PLGA–PVP) layered combinations have been used to provide controlled drug delivery of bovine serum albumin (BSA), rather than instantaneous release [60]. There are only a few published studies demonstrating the
  • and sizes for a wide range of applications. Metals such as titanium [61][62], stainless steel [58][63][64], silicon [65][66][67], ceramics [68][69], biodegradable polymers such as polylactic acid (PLA) [70], PLGA [71], and polyglycolic acid (PGA) [72], and non-degradable polymers such as
PDF
Album
Review
Published 13 Sep 2021

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

  • Sepand Tehrani Fateh,
  • Lida Moradi,
  • Elmira Kohan,
  • Michael R. Hamblin and
  • Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

Graphical Abstract
PDF
Album
Review
Published 11 Aug 2021

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

  • Nikola Geskovski,
  • Nadica Matevska-Geshkovska,
  • Simona Dimchevska Sazdovska,
  • Marija Glavas Dodov,
  • Kristina Mladenovska and
  • Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

Graphical Abstract
  • with higher turnover rates [33]. The authors used alendronate as a surface-exposed ligand for directing bortezomib-loaded nanoparticles consisting of poly(ᴅ,ʟ-lactic-co-glycolic acid) (PLGA) and poly(ethylene glycol) (PEG) to the bone microenvironment, which resulted in a 9.6-fold increase of bone
  • localization of the functionalized nanoparticles relative to the non-functionalized nanoparticles. Additionally, the loaded PLGA–PEG–alendronate nanoparticles demonstrated satisfactory results in myeloma growth inhibition and overall survival of the murine models. Considering the toxicity of bortezomib
PDF
Album
Review
Published 29 Apr 2021

Differences in surface chemistry of iron oxide nanoparticles result in different routes of internalization

  • Barbora Svitkova,
  • Vlasta Zavisova,
  • Veronika Nemethova,
  • Martina Koneracka,
  • Miroslava Kretova,
  • Filip Razga,
  • Monika Ursinyova and
  • Alena Gabelova

Beilstein J. Nanotechnol. 2021, 12, 270–281, doi:10.3762/bjnano.12.22

Graphical Abstract
  • , essential for the interpretation of their biological effects, including cellular uptake [43]. Nevertheless, PEG-SO-MNPs were more efficiently internalized into A549 cells than BSA-SO-MNPs. Interestingly, the magnetic nanospheres (PEG-SO-MNPs coated with polylactic-co-glycolic acid, PLGA) were taken up by
PDF
Album
Supp Info
Full Research Paper
Published 23 Mar 2021

Key for crossing the BBB with nanoparticles: the rational design

  • Sonia M. Lombardo,
  • Marc Schneider,
  • Akif E. Türeli and
  • Nazende Günday Türeli

Beilstein J. Nanotechnol. 2020, 11, 866–883, doi:10.3762/bjnano.11.72

Graphical Abstract
  • polymeric nanoparticles prepared with PBCA and polymers from the poly(ethylene) family such as poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA) [25][26]. Liposomes and other lipidic nanoparticles have also been reported as able to pass the BBB [27], as well as protein-based nanoparticles
  • were observed for PLGA nanoparticles stabilized with PS80 or P188. PLGA nanoparticles loaded with either loperamide or doxorubicin were coated with PS80 or P188 and tested in vivo in rodents [56]. In both cases, P188-coated PLGA nanoparticles showed a higher efficacy than PS80-coated nanoparticles, but
  • both formulations were able to cross the BBB and deliver their cargo. On the other hand, in another study, coumarin-6-loaded PLGA nanoparticles coated with either chitosan or PS80 showed a better crossing ability than P188-coated nanoparticles [57]. This result seems to be in accordance with the
PDF
Album
Review
Published 04 Jun 2020

Rational design of block copolymer self-assemblies in photodynamic therapy

  • Maxime Demazeau,
  • Laure Gibot,
  • Anne-Françoise Mingotaud,
  • Patricia Vicendo,
  • Clément Roux and
  • Barbara Lonetti

Beilstein J. Nanotechnol. 2020, 11, 180–212, doi:10.3762/bjnano.11.15

Graphical Abstract
PDF
Album
Review
Published 15 Jan 2020

Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration

  • Nashrawan Lababidi,
  • Valentin Sigal,
  • Aljoscha Koenneke,
  • Konrad Schwarzkopf,
  • Andreas Manz and
  • Marc Schneider

Beilstein J. Nanotechnol. 2019, 10, 2280–2293, doi:10.3762/bjnano.10.220

Graphical Abstract
  • mucus. Drug carrier systems such as nanoparticles (NPs) require proper surface chemistry and small size to ensure their permeability through the hydrogel-like systems. We have employed a microfluidic system to fabricate poly(lactic-co-glycolic acid) (PLGA) nanoparticles coated with a muco-penetrating
  • was loaded (EE% of ≈68%) very efficiently into the nanoparticles. Finally, the permeability of muco-penetrating PLGA NPs through pulmonary human mucus was assessed; small NPs with a diameter of less than 100 nm showed fast permeation, underlining the potential of microfluidics for such pharmaceutical
  • applications. Keywords: curcumin; human pulmonary mucus; microfluidics; muco-penetrating nanoparticles; nanomedicine; permeability; PLGA nanoparticles; Introduction In the last decades, the application of nanotechnology in medicine has gained significant attention, especially in the biomedical field for
PDF
Album
Full Research Paper
Published 19 Nov 2019

Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity

  • Sebastian Pieper,
  • Hannah Onafuye,
  • Dennis Mulac,
  • Jindrich Cinatl Jr.,
  • Mark N. Wass,
  • Martin Michaelis and
  • Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201

Graphical Abstract
  • . To investigate whether easy-to-prepare nanoparticles made of well-tolerated polymers may circumvent transporter-mediated drug efflux, we prepared poly(lactic-co-glycolic acid) (PLGA), polylactic acid (PLA), and PEGylated PLGA (PLGA-PEG) nanoparticles loaded with the ABCB1 substrate doxorubicin by
  • solvent displacement and emulsion diffusion approaches and assessed their anticancer efficiency in neuroblastoma cells, including ABCB1-expressing cell lines, in comparison to doxorubicin solution. Results: The resulting nanoparticles covered a size range between 73 and 246 nm. PLGA-PEG nanoparticle
  • preparation by solvent displacement led to the smallest nanoparticles. In PLGA nanoparticles, the drug load could be optimised using solvent displacement at pH 7 reaching 53 µg doxorubicin/mg nanoparticle. These PLGA nanoparticles displayed sustained doxorubicin release kinetics compared to the more burst
PDF
Album
Full Research Paper
Published 29 Oct 2019

Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release

  • Mohammad A. Obeid,
  • Ibrahim Khadra,
  • Abdullah Albaloushi,
  • Margaret Mullin,
  • Hanin Alyamani and
  • Valerie A. Ferro

Beilstein J. Nanotechnol. 2019, 10, 1826–1832, doi:10.3762/bjnano.10.177

Graphical Abstract
  • containing the polyanion sodium hyaluronate [8]. Ozeki et al., prepared a curcumin-loaded PEGylated PLGA through microfluidic mixing and achieved an EE of around 50% [20]. Here, high EE of around 60% was achieved using niosomes nanoparticles composed of T85 as a non-ionic surfactant. The encapsulation
PDF
Album
Full Research Paper
Published 05 Sep 2019

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells

  • Hannah Onafuye,
  • Sebastian Pieper,
  • Dennis Mulac,
  • Jindrich Cinatl Jr.,
  • Mark N. Wass,
  • Klaus Langer and
  • Martin Michaelis

Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166

Graphical Abstract
  • bind to doxorubicin via its amino group. Notably, the results differ from a recent similar study in which nanoparticles prepared from poly(lactic-co-glycolic acid) (PLGA) or polylactic acid (PLA), two other biodegradable materials approved by the FDA and EMA for human use [27][28], did not bypass ABCB1
PDF
Album
Supp Info
Full Research Paper
Published 14 Aug 2019

Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles

  • Katrin Partikel,
  • Robin Korte,
  • Dennis Mulac,
  • Hans-Ulrich Humpf and
  • Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 1002–1015, doi:10.3762/bjnano.10.101

Graphical Abstract
  • around poly(lactide-co-glycolide) (PLGA) NPs at different serum concentrations using two substantially different serum types, namely fetal bovine serum (FBS) and human serum. The corona was characterized by means of sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE), Bradford protein
  • assay, zeta potential measurements, and liquid chromatography–mass spectrometry/mass spectrometry (LC–MS/MS). Additionally, the time-dependent cell interaction of PLGA NPs in the absence or presence of a preformed protein corona was assessed by in vitro incubation experiments with the human liver cancer
  • cell line HepG2. Results: Our data revealed that the physiological environment critically affects the protein adsorption on PLGA NPs with significant impact on the NP–cell interaction. Under comparable conditions the protein amount forming the protein corona depends on the serum type used and the serum
PDF
Album
Supp Info
Full Research Paper
Published 06 May 2019

Targeting strategies for improving the efficacy of nanomedicine in oncology

  • Gonzalo Villaverde and
  • Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

Graphical Abstract
  • against specific cell populations. As example, Herceptin is an antibody that recognizes the human epidermal growth factor receptor 2 (HER2) overexpressed in breast cancer cells (HER2+). This antibody has been attached on the surface of poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles loaded with the
PDF
Album
Review
Published 14 Jan 2019

Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells

  • Liga Saulite,
  • Karlis Pleiko,
  • Ineta Popena,
  • Dominyka Dapkute,
  • Ricardas Rotomskis and
  • Una Riekstina

Beilstein J. Nanotechnol. 2018, 9, 321–332, doi:10.3762/bjnano.9.32

Graphical Abstract
  • to U251 glioma cells and induce cancer cell apoptosis [9]. Moreover, MSCs carrying poly(lactic-co-glycolic acid) (PLGA) NPs linked with paclitaxel selectively accumulate in an orthotopic A549 lung tumour model [2]. It has been reported that IFN-beta secreting MSCs could integrate into A375SM melanoma
PDF
Album
Supp Info
Full Research Paper
Published 29 Jan 2018

Development of an advanced diagnostic concept for intestinal inflammation: molecular visualisation of nitric oxide in macrophages by functional poly(lactic-co-glycolic acid) microspheres

  • Kathleen Lange,
  • Christian Lautenschläger,
  • Maria Wallert,
  • Stefan Lorkowski,
  • Andreas Stallmach and
  • Alexander Schiller

Beilstein J. Nanotechnol. 2017, 8, 1637–1641, doi:10.3762/bjnano.8.163

Graphical Abstract
  • ) (PLGA). PLGA microspheres loaded with NO550 dye were prepared through a modified solvent-evaporation method. Microparticles were characterized by a mean hydrodynamic diameter of 3000 nm, zeta potential of −26.000 ± 0.351 mV and a PDI of 0.828 ± 0.298. Under abiotic conditions, NO release was triggered
  • inflammatory and immunological processes. Furthermore, our results on particle-based NO sensing and previous studies in targeting intestinal inflammation via (PLGA)-based microspheres demonstrate that an advanced concept for visualizing intestinal inflammation is tangible. Keywords: functional imaging
  • irregular mucosal patterns and vascular lesions [3]. We developed a novel polymeric microparticle made of biodegradable poly(lactic-co-glycolic acid) (PLGA), which accumulates selectively in inflamed mucosa of patients with inflammatory bowel disease without interfering with the healthy mucosa. This
PDF
Album
Supp Info
Letter
Published 08 Aug 2017

Cationic PEGylated polycaprolactone nanoparticles carrying post-operation docetaxel for glioma treatment

  • Cem Varan and
  • Erem Bilensoy

Beilstein J. Nanotechnol. 2017, 8, 1446–1456, doi:10.3762/bjnano.8.144

Graphical Abstract
  • suppressor gene delivery. Their results showed that the prepared nanoparticles enhanced the delivery of tumor suppressor genes on U87 and U251 glioma cells [24]. Wang et al. used core–shell nanoparticles for drug and gene co-delivery. They prepared magnetic PLGA/polymeric liposome carriers to achieve
  • nanoparticles were studied for glioma therapy by Qian et al. where a PLGA nanoparticle surface was modified with CS and cellular uptake of nanoparticles was determined. They showed that cellular uptake is related to chitosan concentration and particle size. According to their results, chitosan modification
PDF
Album
Full Research Paper
Published 12 Jul 2017

Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation

  • Kati Erdmann,
  • Jessica Ringel,
  • Silke Hampel,
  • Manfred P. Wirth and
  • Susanne Fuessel

Beilstein J. Nanotechnol. 2017, 8, 1307–1317, doi:10.3762/bjnano.8.132

Graphical Abstract
  • PLGA-PEG nanoparticles evoked an improved inhibition of cancer cell and tumor tissue growth compared to free DTX [38]. The superiority of CNFs in combination treatments compared to CNTs might be explained by their different morphology (Table 4). While CNTs consist of concentric graphene cylinders with
PDF
Album
Supp Info
Full Research Paper
Published 23 Jun 2017

Dispersion of single-wall carbon nanotubes with supramolecular Congo red – properties of the complexes and mechanism of the interaction

  • Anna Jagusiak,
  • Barbara Piekarska,
  • Tomasz Pańczyk,
  • Małgorzata Jemioła-Rzemińska,
  • Elżbieta Bielańska,
  • Barbara Stopa,
  • Grzegorz Zemanek,
  • Janina Rybarska,
  • Irena Roterman and
  • Leszek Konieczny

Beilstein J. Nanotechnol. 2017, 8, 636–648, doi:10.3762/bjnano.8.68

Graphical Abstract
  • improve the biocompatibility of nanotubes and increase their retention time in the organism. The retention time of carbon nanotubes is longer than that of PLGA particles or immunoliposomes which are quickly taken up by the reticuloendothelial system cells, thus decreasing the efficiency of drug delivery
PDF
Album
Full Research Paper
Published 16 Mar 2017
Other Beilstein-Institut Open Science Activities